 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The subscription figures of Rossari Biotech Limited IPO subscription on Day 1 (July 13, 2020) at 05.00 pm.
Overall - 0.60 times
QIB - 0.41 times
HNI - 0.11 times
Retail - 0.92 times
| Issue Highlights | |
| Issue Size (Fresh+OFS) | Rs 496.24 crore (Fresh Issue Rs.50 crore and OFS Rs.446.25 Crore) | 
| Price Band | Rs. 423 - Rs. 425 | 
| Allocation Category wise | QIB: 50% HNI: 15% and RII 35% | 
| Issue Period | July 13, 2020 to July 15, 2020 | 
| BRLMs | Axis Capital Limited & ICICI Securities Ltd. | 
| Advisor | Axcelus Finserv Private Limited | 
| Promoters | Mr. Edward Menezes-Executive Chairman and Mr. Sunil Chari - Managing Director of Rossari Biotech Limited |